Capital Advisors Ltd’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2K Hold
16
﹤0.01% 1108
2026
Q1
$2K Hold
16
﹤0.01% 1095
2025
Q4
$2K Hold
16
﹤0.01% 1073
2025
Q3
$2K Hold
16
﹤0.01% 1059
2025
Q2
$2K Hold
16
﹤0.01% 1056
2025
Q1
$2K Hold
16
﹤0.01% 1046
2024
Q4
$1K Hold
16
﹤0.01% 1185
2024
Q3
$2K Hold
16
﹤0.01% 1056
2024
Q2
$1K Hold
16
﹤0.01% 1166
2024
Q1
$1K Buy
16
+7
+78% +$513 ﹤0.01% 1170
2023
Q4
$1K Hold
9
﹤0.01% 1122
2023
Q3
$1K Hold
9
﹤0.01% 1112
2023
Q2
$1K Hold
9
﹤0.01% 1126
2023
Q1
$0 Sell
9
-31
-78% -$1.8K ﹤0.01% 1283
2022
Q4
$2K Buy
40
+31
+344% +$1.69K ﹤0.01% 844
2022
Q3
$0 Sell
9
-2
-18% -$100 ﹤0.01% 1301
2022
Q2
$1K Buy
+11
New +$564 ﹤0.01% 767
2022
Q1
Sell
-6
Closed 977
2021
Q4
$0 Buy
+6
New +$310 ﹤0.01% 844

Other funds holding EHC

Capital Advisors Ltd's EHC Position: Q2 2026 in Review

Capital Advisors Ltd held its Encompass Health (EHC) position steady in Q2 2026 at 16 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Capital Advisors Ltd first reported a position in EHC in Q4 2021 and has held it in 18 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Capital Advisors Ltd held 16 shares of Encompass Health worth $2K as of Q2 2026.
  • Capital Advisors Ltd left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1108 holding.
  • Capital Advisors Ltd first reported a position in Encompass Health in Q4 2021 and has held it in 18 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.